Ozempic may help treat kidney disease in diabetic patients

The New York Times May 24, 2024, 12:00 PM UTC

Summary: Semaglutide, found in Ozempic and Wegovy, significantly reduced kidney complications, heart issues, and death in Type 2 diabetes patients with chronic kidney disease. The trial's success led Novo Nordisk to halt it early. The company plans to seek FDA approval to update Ozempic's label for treating chronic kidney disease in diabetic patients. Chronic kidney disease affects over one in seven US adults and has no cure.

Full article

Article metrics
Significance5.7
Scale & Impact0.0
Positivity7.0
Credibility9.5

What is this?

This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.

My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.

Read more about how I calculate significance, or see today's top ranked news on the main page:

See today's news rankings

Timeline:

  1. [2.6]
    Weight-loss meds linked to surprise pregnancies, dubbed "Ozempic babies." (WATE 6 On Your Side)
    142d 14h
    Source
  2. [2.6]
    Weight loss jabs may affect contraception, women urged caution (The Sun)
    142d 15h
    Source
  3. [2.4]
    Weight-loss meds linked to surprise pregnancies, fertility improvement noted (WKRN News 2)
    143d 3h
    Source
  4. [3.4]
    Caution advised for women on Wegovy and Ozempic (Irish Examiner)
    143d 11h
    Source
  5. [4.5]
    Pair effective contraception with GLP-1 agonist weight loss meds (The Guardian)
    143d 12h
    Source
  6. [3.8]
    Wegovy obesity drug arrives in Canada, raising hopes (The Globe and Mail)
    146d 1h
    Source
  7. [3.6]
    Ozempic cuts death risk in diabetes patients with kidney disease (STAT)
    146d 17h
    Source
  8. [4.7]
    Wegovy's benefits questioned, lifestyle changes recommended for weight loss (Financial Times)
    148d 4h
    Source
  9. [2.3]
    New weight loss drug more effective than Ozempic (New York Post )
    150d 8h
    Source
  10. [3.6]
    Online pharmacy offers unapproved weight loss drugs, bypassing FDA (The Verge)
    150d 10h
    Source
  11. [4.6]
    Gene test predicts success with weight loss drugs (CNN)
    150d 23h
    Source
  12. [3.5]
    Genetic profile predicts response to weight-loss drug Wegovy (Marketscreener.com)
    151d 0h
    Source
  13. [4.2]
    Ozempic weight-loss drug shows promise but raises concerns (Vox.com)
    151d 17h
    Source
  14. [4.2]
    Ozempic weight loss drug causes body shape changes (India Today)
    152d 23h
    Source